Related Experiment Video
Updated: Jun 25, 2026
Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq
Published on: March 12, 2021
Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line
Doris Hendig1, Thomas Langmann, Ralf Zarbock
1Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Abstract:
Chemotherapy failure was reported in treatment of retinoblastoma suggesting a role for ATP-binding cassette (ABC) proteins. Little is known about the expression pattern of ABC proteins in this cancer type. We investigated the gene expression profile of 47 ABC proteins in the human retinoblastoma cell line Y79 by TaqMan low-density array. Analysis revealed 31 ABC transporter genes expressed in this tumor cell line. Y79 cells demonstrate high gene expression of ABCA7, ABCA12, ABCB7, ABCB10, ABCC1, ABCC4, ABCD3, ABCE1, ABCF1, ABCF2, and ABCF3 (more than twofold compared to pooled RNA from different tissues). Moreover, we show that Y79 cells exhibit an active calcein efflux pointing to multidrug resistance protein (MRP)-like transporter activity. In summary, we present for the first time an ABC transporter gene expression profile in cells derived from retinoblastoma. Most of the highly expressed ABC transporter genes are typical markers of cancer cells and might exhibit potential targets for medical treatment of retinoblastoma.
Insights
Chemotherapy failure in retinoblastoma may involve ATP-binding cassette (ABC) proteins. This study profiles ABC transporter gene expression in Y79 cells, revealing potential therapeutic targets for this eye cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Chemotherapy resistance is a challenge in retinoblastoma treatment.
- ATP-binding cassette (ABC) proteins are implicated in drug resistance.
- The expression profile of ABC proteins in retinoblastoma is largely unknown.
Purpose of the Study:
- To investigate the gene expression profile of ATP-binding cassette (ABC) proteins in the Y79 retinoblastoma cell line.
- To identify potential therapeutic targets for retinoblastoma based on ABC transporter expression.
Main Methods:
- Utilized TaqMan low-density array to analyze the expression of 47 ABC transporter genes.
- Quantified gene expression levels in the Y79 human retinoblastoma cell line.
- Assessed transporter activity via calcein efflux assay.
Main Results:
- Identified expression of 31 ABC transporter genes in Y79 cells.
- Observed high gene expression of specific ABC transporters including ABCA7, ABCA12, ABCB7, ABCB10, ABCC1, ABCC4, ABCD3, ABCE1, ABCF1, ABCF2, and ABCF3.
- Demonstrated active calcein efflux, indicating multidrug resistance protein (MRP)-like transporter activity.
Conclusions:
- This study provides the first comprehensive ABC transporter gene expression profile in retinoblastoma cells.
- Highly expressed ABC transporter genes are common cancer markers and potential therapeutic targets.
- Understanding ABC transporter expression may lead to novel treatment strategies for retinoblastoma.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...